• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
157.04 3 (1.99%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    156.00

  • Today’s High

    157.04

  • Open

    156.00

  • Perv Close

    153.97

  • 52W Low

    93.50

  • 52W High

    198.86

Key Indicators

  • P/E(TTM)

    151.92

  • Mar.Cap (₹Cr.)

    462.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    39.06

  • Debt-Equity Ratio

    1.99

  • AGM Date

    01-Aug-2025

  • EPS

    1.04

  • P/E Ratio

    151.92

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    462.60

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.46

  • BV (₹)

    39.10

  • Sales( ₹ in Cr.)

    82.56

  • NP (in Cr.)

    3.05

  • NP Var(%)

    101.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    465.42

  • 52 Week High

    198.86

  • 52 Week Low

    93.50

  • Price BSE

    158.0

  • Price NSE

    157.00

  • Market Capital( in Cr.)

    465.42

  • P/C Ratio

    100.00

  • P/E Ratio

    152.50

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 79.49 55.54 76.97 77.27 69.69 55.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 79.49 55.54 76.97 77.27 69.69 55.03
Other Income 0.96 0.12 0.95 0.96 0.41 2.88
Stock Adjustments -1.40 -2.01 2.93 3.34 3.29 1.14
Total Income 79.05 53.65 80.85 81.57 73.39 59.05
EXPENDITURE :            
Raw Materials 56.59 39.48 53.59 52.56 50.13 40.57
Power and Fuel Cost 1.73 1.58 1.64 2.70 2.90 2.56
Employee Cost 10.09 10.65 10.88 12.04 11.16 10.04
Other Manufacturing Expenses 1.34 1.22 3.77 3.17 3.75 3.45
Selling and Administration Expenses 4.05 4.91 6.39 6.57 5.88 4.86
Miscellaneous Expenses 1.07 1.50 1.75 2.63 3.08 3.05
Employee Benefit Expenses 10.09 10.65 10.88 12.04 11.16 10.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 74.87 59.34 78.02 79.67 76.90 64.53
Operating Profit 4.17 -5.70 2.82 1.91 -3.52 -5.49
Interest 0.84 0.77 0.67 3.25 3.35 2.96
Gross Profit 3.33 -6.47 2.15 -1.34 -6.87 -8.45
Depreciation 1.77 1.72 1.49 7.09 6.65 6.50
Profit Before Tax 1.56 -8.19 0.66 -8.43 -13.52 -14.95
Current Tax 0.03 0.00 0.00 7.15 9.12 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 1.74 -0.14
Reported Net Profit 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Extraordinary Items 0.01 0.01 0.26 -0.06 -1.18 0.17
Adjusted Net Profit 1.52 -8.19 0.41 -15.53 -23.20 -14.98
Adjustment below Net Profit 0.00 0.00 0.00 -18.73 -0.05 0.00
P & L Balance brought forward -36.30 -28.12 -28.79 5.53 29.96 44.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -34.78 -36.30 -28.12 -28.79 5.53 29.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.58 -3.31 0.27 -6.31 -9.87 0.00
Earnings Per Share(Adj)-Unit Curr 0.58 -3.28 0.27 -6.25 -9.77 0.00
Book Value 26.49 22.98 26.31 25.99 39.84 64.96
Book Value(Adj)-Unit Curr 26.49 22.76 26.06 25.74 39.45 53.64

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 141,340 0.48 141,340 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,057,451 10.38 3,057,451 2
2] Non Institution
Bodies Corporate 977,700 3.32 977,700 65
Clearing Members 4,460 0.02 4,460 2
Directors of their Relatives 100 0.00 100 1
Employees 1,865 0.01 537 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 142,259 0.48 142,259 133
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 344,251 1.17 344,251 233
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,216,220 14.31 4,216,220 66
Individuals holding nominal share capital up to Rs. 1 lakh 5,212,650 17.70 5,212,278 9,800
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,899,505 37.00 10,897,805 10,307
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 10,317

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 158.00 80.44 79.49 151.92 2.72
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10